CompanyDrug

Boehringer Ingelheim Gets NMPA Approval for Brigimadlin Safety and Efficacy Study in China

Policy / Regulatory

NHSA Unveils Measures to Enhance Smart Monitoring and Auditing of Basic Medical Insurance Funds

CompanyDrug

MSD’s Sotatercept Demonstrates Positive Interim Results in Phase III PAH Studies

CompanyDeals

Suzhou Porton Biologics Partners with BRL Medicine to Advance Gene and Cell Therapy Pipeline

CompanyDrug

AstraZeneca’s Tagrisso Combination Therapy Shows Improved Efficacy in EGFR-mutated NSCLC

CompanyDeals

Jiangsu Recbio and Yikang Biological Partner to Develop RSV Preventative Vaccine

CompanyDrug

Janssen Reports Positive Results from Phase Ib/II Study of Rybrevant Combo in EGFR-mutated NSCLC

CompanyDrug

AstraZeneca’s Enhertu Shows Promising Results in Phase II HER2-mutant NSCLC Trial

CompanyDeals

Innovent Biologics Plans Share Placement to Raise HKD 2.36 Billion for Global Expansion

Policy / Regulatory

NMPA Pilots Priority Review for Rare Disease Formula Foods, Aims to Reduce Approval Time

CompanyMedical Device

Huadong Medicine’s Subsidiary Viora Ltd’s V20 Accepted for NMPA Review

CompanyDrug

Gan & Lee Pharmaceuticals Initiates Phase II Clinical Study for Weekly Insulin GZR4